Document is current
Any future updates will be listed below
-
Authors
Fox, Katelyn
Hart, Chantelle N.
Phelan, Suzanne
Ventura, Alison K.
Wing, Rena
Jelalian, Elissa
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R56DK108661, R56DK108661, R56DK108661, R56DK108661, R56DK108661)
National Heart, Lung, and Blood Institute (U01HL114377, U01HL114377)
- License Information
-
More Information
Article History
Received: 11 April 2024
Accepted: 12 June 2024
First Online: 19 June 2024
Declarations
:
: All participants provided written informed consent to participate to HB/CS and MTT. All procedures were approved by the Institutional Review Boards at the Miriam Hospital and California Polytechnic State University in accordance with the Declaration of Helsinki. The HB/CS trial was registered at as NCT01545934 with study completion June, 2020.
: Not applicable.
: The authors do not have competing interests relevant to this paper. Dr. Hart currently serves as a Consultant on a grant funded by the Novo Nordisk Foundation that is unrelated to this work. Dr. Phelan has a grant from WW International that is unrelated to this work. Drs. Ventura, Jelalian, Wing, and Fox do not have any financial interests to disclose.
